PNTG

The Pennant Group, Inc.

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

The Pennant Group, Inc. (PNTG) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B); its weakest is Profitability (C+). The rating has held at C+ for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.8 / 5.0
C+
Value
C+
Factor Score 2.7 / 5.0
Growth
C+
Factor Score 2.6 / 5.0
Profitability
C+
Factor Score 2.6 / 5.0
Momentum
B
Factor Score 3.4 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 35.7
EV / EBITDA 21.3
Rev Growth YoY 32.0%
Gross Margin 19.4%
Price Return 3M -7.9%
Price Return 12M 42.9%
Catalyst Signal 0.00
Market Cap $1.3B
TTM Revenue $1.2B
Price / Sales 1.1
ROE 11.2%

Historical Factor Score Progression

Held C+ for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-14 C+ (2.7) C+ (2.6) C+ (2.6) B (3.4) C+ (2.6) C+ (2.8)
2026-11-07 C+ (2.6) C+ (2.6) C+ (2.6) B (3.2) C+ (2.7) C+ (2.8)
2026-10-31 C (2.5) C (2.4) C+ (2.6) B (3.4) C+ (2.7) C+ (2.7)
2026-10-24 C (2.5) C (2.4) C+ (2.6) B (3.2) C+ (2.6) C+ (2.7)
2026-10-17 C (2.5) C (2.4) C+ (2.6) B (3.2) C+ (2.6) C+ (2.7)
Page 1 of 5